Search Within

Anthony Joseph Proli II

Formats
  1. Meeting Abstract (15)
  2. Journal Article (5)
  3. Research Letter (1)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Bone Marrow Transplant (19)
  4. Center for Hematologic Malignancies (19)
  5. Clinical Pharmacy Specialists (19)
  6. Survivorship Research (15)

More Groups

People
  1. Andrew Lin (19)
  2. Sergio Giralt (16)
  3. Valkal Bhatt (16)
  4. Miguel-Angel Perales (13)
  5. Lauren DeRespiris (10)
  6. Ann Jakubowski (9)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (4)
  4. 2019 (6)
  5. 2017 (3)
  6. 2016 (4)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (11)
  2. Bone Marrow Transplantation (3)
  3. Blood (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. Clinical Pharmacokinetics (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. Elsevier Inc. (13)
  2. Nature Publishing Group (3)
  3. American Society of Hematology (2)
  4. Adis International Ltd (1)
  5. Taylor & Francis Group (1)
  6. Wiley Blackwell (1)

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation
    Journal Article

    Lin, A.; Brown, S.; Maloy, M.; Ruiz, J. D.; Devlin, S.; DeRespiris, L.; Proli, A.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: Towards individualized dosing regimens
    Journal Article

    Shah, G. L.; Boelens, J. J.; Carlow, D.; Lin, A.; Schofield, R.; Cruz Sitner, N.; Alperovich, A.; Ruiz, J.; Proli, A.; Dahi, P.; more...
    Clinical Pharmacokinetics (2022)

    Fulltext@MSK | Save
  • Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis
    Journal Article

    Lin, A.; Flynn, J.; DeRespiris, L.; Figgins, B.; Griffin, M.; Lau, C.; Proli, A.; Devlin, S. M.; Cho, C.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Pharmacokinetics of melphalan in lymphoma patients undergoing beam and autologous hematopoietic stem cell transplant
    Meeting Abstract

    Dahi, P.; Lin, A.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; Derespiris, L.; Figgins, B.; Griffin, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Research Letter

    Maples, K. T.; Maloy, M.; Devlin, S.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Effect of melphalan exposure in patients with lymphoma undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Lin, A.; Dahi, P. B.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; DeRespiris, L.; Figgins, B.; Griffin, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Successful personalization of propylene glycol free melphalan (PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT) using pharmacokinetic (PK)-directed dosing
    Meeting Abstract

    Shah, G. L.; Lin, A.; Kamrowski, A.; Carino, C. A.; Schofield, R.; Devlin, S. M.; Bhatt, V.; Proli, A. J.; Chung, D. J.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of the effect of isavuconazole on immunosuppressant serum blood levels and intravenous to oral dose adjustments
    Meeting Abstract

    Proli, A. J.; Bhatt, V.; Lin, A.; Lau, C.; Griffin, M.; DeRespiris, L.; Maples, K. T.; Figgins, B.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients
    Meeting Abstract

    Maples, K. T.; Maloy, M. A.; Lin, A.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Papanicolaou, G. A.; Seo, S. K.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Letermovir in allogeneic hematopoietic cell transplantation: Beyond the label
    Meeting Abstract

    Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save